Skip to main content
Clinical Trials/CTRI/2024/02/063053
CTRI/2024/02/063053
Not yet recruiting
Phase 2

Evaluation of the efficacy and safety of topical application of Tukhm-e-Turb and Tukhm-e-Jarjir in the management of Kalf (Melasma) - NI

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue
Sponsor
Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital

Eligibility Criteria

Inclusion Criteria

  • 1 Clinically diagnosed patients of Kalf (Melasma) by wood’s lamp examination.
  • 2 Patients with Fitzpatrick skin types III, IV and V
  • 3 Patients of all sexes.
  • 4 Patients who are willing to sign the written consent form prior to participation in the study.

Exclusion Criteria

  • 1 Pregnant and lactating women.
  • 2 Patients having used any cosmetic depigmenting agent within 2 weeks prior to inclusion in the study.
  • 3 Female on oral contraceptives and hormone therapy at the time of study.
  • 4 Patients having used topical or systemic corticosteroid within 1 month prior to inclusion in the study.
  • 5 Patients having history of laser treatment or dermabrasion or deep facial peels within the past 3 months.
  • 6 Patients who have a known history or clinically relevant allergy, to any study medication components.
  • 7 Patients who have a known history of renal insufficiency, severe liver or heart diseases, neurological disorders, malignancy, HIV infection, AIDS, etc.
  • 8 Patients unlikely to comply with the study protocol.

Outcomes

Primary Outcomes

Not specified

Similar Trials